Sign up
Pharma Capital

Ellen Kelleher

Journalist

Ellen Kelleher is an experienced journalist who previously spent over a decade working as a business reporter in the London and New York bureaus of the Financial Times.

1523447180_Ellen.jpg


© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.